These signals can promote either a pro-tumor M2 phenotype (e.g., IL-4, IL-10, TGF-beta, and CCL2) [171] or can drive TAMs towards an anti-tumor M1 phenotype (e.g., IFN-gamma and TNF-alpha) [172]. The gene discussed is TNF; the disease is neoplasm.